查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
水肿临床试验市场 - 成长、未来展望、竞争分析，2023-2031
市场调查报告书
商品编码
1397467

水肿临床试验市场 - 成长、未来展望、竞争分析，2023-2031

Edema Clinical Trials Market - Growth, Future Prospects and Competitive Analysis, 2023 - 2031
出版日期: | 出版商: Acute Market Reports | 英文 112 Pages | 商品交期: 最快1-2个工作天内

价格

水肿临床试验市场经历了重大演变，由于研究方法的进步以及对不同进入者群体的日益关注，预计在 2023-2031 年预测期内将以 5.5% 的复合年增长率增长。 随着我们从收入可观的 2022 年转向 2023 年至 2031 年的预测期，水肿临床试验市场预计将继续扩大。 临床试验中继续采用的创新策略预计将塑造水肿治疗的格局，解决不同患者群体的复杂性，并为更有效和以患者为中心的干预措施铺平道路。

治疗方法的进展

水肿临床试验市场的最□□大驱动力是治疗方法的持续发展。 正在进行的临床试验正在探索创新机制，以更有效地解决水肿问题，新型候选药物和干预措施的出现证明了这一点。 针对特定途径（例如血管通透性和淋巴功能）的研究性治疗在早期试验中显示出有希望的结果。 这些进步反映了为提高治疗效果和减少副作用而做出的共同努力，为更有针对性和个人化的治疗铺平了道路。

更重视儿科研究

塑造水肿临床试验格局的一个重要驱动力是对儿科研究的日益重视。 认识到儿科族群面临的独特挑战和独特的生理反应，最近的临床试验专注于开发专门针对儿童的实证干预措施。 这一转变透过将儿科队列纳入多阶段试验来证明，以确保针对该族群的水肿治疗的安全性和有效性。 透过解决儿科患者未满足的医疗需求，这些试验有助于更全面地了解不同年龄层的水肿管理。

数位科技的不断融合

推动水肿临床试验市场的另一个关键因素是数位技术的日益整合。 从电子数据采集系统到监测水肿相关参数的可穿戴设备，临床试验正在利用数位技术创新来提高数据准确性、简化患者监测并提高整体试验效率。 即时数据收集和分析使研究人员能够做出明智的决策，加快临床试验的步伐，并有助于及时开发有效的水肿治疗方法。

病患招募与留任的挑战

水肿临床试验市场的一个主要限制因素是病患招募和保留的持续挑战。 儘管治疗方法和数位技术取得了进步，但招募多样化且具代表性的参与者仍然是一个复杂的挑战。 这种限制的证据是难以招募足够数量的合格参与者，从而导致试验持续时间更长和成本增加。 此外，在一些试验中观察到的高流失率凸显了需要创新策略来提高患者在整个试验期间的参与度和保留率。

III 期试验主导市场

2022年水肿临床试验市场在不同阶段都有可观的收入，其中III期试验收入最高。 然而，IV 期试验显示在 2023-2031 年预测期内复合年增长率最高。 这代表着向上市后监测和对长期治疗结果的持续探索的转变。 这种动态细分突显了水肿临床研究的不断发展的性质，重点是晚期和上市后监测。

依参与者划分：成人细分市场主导市场

2022 年市场参与者细分显示，成人收入强劲，反映出临床试验对此细分市场的关注。 然而，预测期内复合年增长率最高的是儿科，凸显了人们越来越认识到儿科研究在解决年轻人水肿的重要性。 同时，老年病学展示了一种综合方法，在临床试验设计中考虑了老年患者的独特特征，并保持了强劲的收入。

北美仍处于世界领先地位

2022年水肿临床试验市场呈现地理差异化趋势，其中北美收入领先。 然而，亚太地区的复合年增长率最高，反映出临床试验活动的激增和研究基础设施投资的增加。 考虑到收入和复合年增长率之间的平衡，这些地理趋势凸显了水肿临床试验的全球性质，不同地区对研究进展做出了独特的贡献。

预测期内市场竞争将会加剧

在竞争格局中，Pfizer, Novartis, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche, Bayer, Genentech, Biogen, Inflammasome Therapeutics, Sanofi, OcuTerra Therapeutics等大公司都在进行技术创新。塑造水肿临床试验的未来。 这些主要公司预计将在 2022 年实现可观收入，并在 2023 年至 2031 年期间继续成长。 他们的策略重点是开发先进的治疗方法、强调儿科研究和利用数位技术，这使他们成为水肿临床试验领域的一支有影响力的力量。 随着市场的发展，这些参与者预计将在推进临床研究方面发挥关键作用，并最终为开发更有效的水肿治疗方法做出贡献。

目录

第一章前言

  • 报告内容
    • 报告的目的
    • 目标受众
    • 提供的主要产品
  • 市场区隔
  • 调查方法
    • 第一阶段-二次调查
    • 第二阶段 - 初步调查
    • 第三阶段-专家评审
    • 先决条件
    • 采用的方法

第 2 章执行摘要

第三章水肿临床试验市场：竞争分析

  • 主要供应商的市场地位
  • 供应商采取的策略
  • 主要产业战略
  • 层级分析：2022 年与 2031 年

第四章水肿临床试验市场：宏观分析与市场动态

  • 简介
  • 2021-2031年全球水肿临床试验市场价值
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 主要挑战
    • 主要机会
  • 促进因素和抑制因素的影响分析
  • 跷跷板分析
  • Portela 的五力模型 € (TM)
    • 供应商实力
    • 买家力量
    • 替代品的威胁
    • 新进入者的威胁
    • 竞争公司之间的对抗关係
  • PESTEL 分析
    • 政治局势
    • 经济情势
    • 技术版图
    • 法律状况
    • 社会状况

第五章水肿临床试验市场：依阶段 2021-2031

  • 市场概览
  • 成长/利润分析：2022 年与 2031 年
  • 市场区隔
    • 第一阶段
    • 第二阶段
    • 第三阶段
    • 第四阶段

第 6 章水肿临床试验市场：依参与者 2021-2031

  • 市场概览
  • 成长/利润分析：2022 年与 2031 年
  • 市场区隔
    • 儿科
    • 成人
    • 老年医学

第 7 章水肿临床试验市场：依研究设计 2021-2031

  • 市场概览
  • 成长/利润分析：2022 年与 2031 年
  • 市场区隔
    • 干预试验
    • 观察测试
    • 扩充存取试用版

第 8 章水肿临床试验市场：依类型 2021-2031

  • 市场概览
  • 成长/利润分析：2022 年与 2031 年
  • 市场区隔
    • 全身水肿
    • 局部水肿

第九章北美水肿临床试验市场2021-2031

  • 市场概览
  • 水肿临床试验市场：依阶段 2021-2031
  • 水肿临床试验市场：依参与者划分，2021-2031 年
  • 水肿临床试验市场：依研究设计 2021-2031
  • 水肿临床试验市场：依类型 2021-2031
  • 水肿临床试验市场：依地区划分 2021-2031
    • 北美
      • 美国
      • 加拿大
      • 其他北美地区

第 10 章英国与欧盟水肿临床试验市场 2021-2031

  • 市场概览
  • 水肿临床试验市场：依阶段 2021-2031
  • 水肿临床试验市场：依参与者划分，2021-2031 年
  • 水肿临床试验市场：依研究设计 2021-2031
  • 水肿临床试验市场：依类型 2021-2031
  • 水肿临床试验市场：依地区划分 2021-2031
    • 英国和欧盟
      • 英国
      • 德国
      • 西班牙
      • 义大利
      • 法国
      • 其他欧洲地区

第11章亚太水肿临床试验市场2021-2031

  • 市场概览
  • 水肿临床试验市场：依阶段 2021-2031
  • 水肿临床试验市场：依参与者划分，2021-2031 年
  • 水肿临床试验市场：依研究设计 2021-2031
  • 水肿临床试验市场：依类型 2021-2031
  • 水肿临床试验市场：依地区划分 2021-2031
    • 亚太地区
      • 中国
      • 日本
      • 印度
      • 澳大利亚
      • 韩国
      • 其他亚太地区

第十二章拉丁美洲水肿临床试验市场2021-2031

  • 市场概览
  • 水肿临床试验市场：依阶段 2021-2031
  • 水肿临床试验市场：依参与者划分，2021-2031 年
  • 水肿临床试验市场：依研究设计 2021-2031
  • 水肿临床试验市场：依类型 2021-2031
  • 水肿临床试验市场：依地区划分 2021-2031
    • 拉丁美洲
      • 巴西
      • 墨西哥
      • 其他拉丁美洲地区

第十三章2021-2031年中东及非洲水肿临床试验市场

  • 市场概览
  • 水肿临床试验市场：依阶段 2021-2031
  • 水肿临床试验市场：依参与者划分，2021-2031 年
  • 水肿临床试验市场：依研究设计 2021-2031
  • 水肿临床试验市场：依类型 2021-2031
  • 水肿临床试验市场：依地区划分 2021-2031
    • 中东/非洲
      • 海湾合作委员会
      • 非洲
      • 其他中东/非洲地区

第十四章公司简介

  • Pfizer Inc.
  • Novartis AG
  • Johnson & Johnson
  • Otsuka Holdings
  • F. Hoffmann-La Roche Ltd.
  • Bayer
  • Genentech Inc
  • Biogen
  • Inflammasome Therapeutics
  • Sanofi S.A.
  • OcuTerra Therapeutics
  • 其他主要公司
Product Code: 140025-12-23

The edema clinical trials market is undergoing significant advancements and is expected to grow at a CAGR of 5.5% during the forecast period of 2023 to 2031, fueled by evolving research methodologies and a growing focus on diverse participant demographics. As we transition from 2022, marked by substantial revenues, to the forecast period of 2023 to 2031, the Edema Clinical Trials market is poised for continued expansion. The ongoing innovative strategies employed in clinical trials are expected to shape the landscape of edema treatment, addressing the complexities of diverse patient populations and paving the way for more effective and patient-centric interventions.

Advancements in Therapeutic Approaches

The foremost driver in the Edema Clinical Trials market is the continuous evolution of therapeutic approaches. As evidenced by the emergence of novel drug candidates and interventions, ongoing clinical trials are exploring innovative mechanisms to address edema more effectively. Investigational treatments targeting specific pathways, such as vascular permeability and lymphatic function, have demonstrated promising results in early-phase trials. These advancements reflect a concerted effort to enhance treatment efficacy and reduce adverse effects, paving the way for more targeted and personalized interventions.

Increased Emphasis on Pediatric Research

A crucial driver shaping the landscape of edema clinical trials is the increased emphasis on pediatric research. Recognizing the unique challenges and distinct physiological responses in pediatric populations, recent trials have focused on developing evidence-based interventions specifically tailored to children. This shift is evident in the inclusion of pediatric cohorts in multi-phase trials, ensuring the safety and efficacy of edema treatments for this demographic. By addressing the unmet medical needs of pediatric patients, these trials contribute to a more comprehensive understanding of edema management across diverse age groups.

Growing Integration of Digital Technologies

Another key driver propelling the Edema Clinical Trials market is the growing integration of digital technologies. From electronic data capture systems to wearable devices monitoring edema-related parameters, clinical trials are leveraging digital innovations to enhance data accuracy, streamline patient monitoring, and improve overall trial efficiency. Real-time data collection and analysis enable researchers to make informed decisions, accelerating the pace of clinical trials and contributing to the timely development of effective edema treatments.

Challenges in Patient Recruitment and Retention

A significant restraint in the Edema Clinical Trials market is the persistent challenge of patient recruitment and retention. Despite the advancements in therapeutic approaches and digital technologies, enrolling a diverse and representative participant pool remains a complex task. Evidence supporting this restraint includes instances of prolonged trial timelines and increased costs due to difficulties in recruiting a sufficient number of eligible participants. Additionally, the high attrition rates observed in some trials underscore the need for innovative strategies to enhance patient engagement and retention throughout the trial duration.

By Phase: Phase III trials Dominates the Market

In 2022, the Edema Clinical Trials market experienced substantial revenue across different phases, with Phase III trials generating the highest revenue. However, Phase IV trials demonstrated the highest CAGR during the forecast period from 2023 to 2031, indicating a shift towards post-marketing research and continued exploration of long-term treatment outcomes. This dynamic segmentation underscores the evolving nature of clinical research in edema, emphasizing both advanced stages and post-marketing surveillance.

By Participant: The Adults Segment Dominates the Market

Market segmentation by participants in 2022 showcased robust revenue streams from adults, reflecting the predominant focus on this demographic in clinical trials. However, Pediatrics demonstrated the highest CAGR during the forecast period, highlighting a growing recognition of the importance of pediatric research in addressing edema in younger populations. Simultaneously, Geriatrics maintained substantial revenue, illustrating a comprehensive approach that considers the unique characteristics of elderly patients in clinical trial design.

North America Remains the Global Leader

Geographically, the Edema Clinical Trials market exhibited diverse trends in 2022, with North America leading in revenue generation. However, the Asia-Pacific region showcased the highest CAGR, reflecting a surge in clinical trial activities and increasing investment in research infrastructure. Balancing revenue and CAGR, these geographic trends underscore the global nature of edema clinical trials, with diverse regions contributing uniquely to research advancements.

Market Competition to Intensify during the Forecast Period

In the competitive landscape, top players such as Pfizer Inc., Novartis AG, Johnson & Johnson, Otsuka Holdings, F. Hoffmann-La Roche Ltd., Bayer, Genentech, Inc, Biogen, Inflammasome Therapeutics, Sanofi S.A. and OcuTerra Therapeutics are driving innovation and shaping the future of edema clinical trials. These key players reported substantial revenues in 2022, expecting continued growth from 2023 to 2031. Their strategic focus on developing advanced therapeutic approaches, emphasizing pediatric research, and leveraging digital technologies positions them as influential entities in the edema clinical trials landscape. As the market evolves, these players are anticipated to play a pivotal role in advancing clinical research, ultimately contributing to the development of more effective treatments for edema.

Historical & Forecast Period

This study report represents analysis of each segment from 2021 to 2031 considering 2022 as the base year. Compounded Annual Growth Rate (CAGR) for each of the respective segments estimated for the forecast period of 2023 to 2031.

The current report comprises of quantitative market estimations for each micro market for every geographical region and qualitative market analysis such as micro and macro environment analysis, market trends, competitive intelligence, segment analysis, porters five force model, top winning strategies, top investment markets, emerging trends and technological analysis, case studies, strategic conclusions and recommendations and other key market insights.

Research Methodology

The complete research study was conducted in three phases, namely: secondary research, primary research, and expert panel review. key data point that enables the estimation ofEdema Clinical Trials market are as follows:

Research and development budgets of manufacturers and government spending

Revenues of key companies in the market segment

Number of end users and consumption volume, price and value.

Geographical revenues generate by countries considered in the report:

Micro and macro environment factors that are currently influencing the Edema Clinical Trials market and their expected impact during the forecast period.

Market forecast was performed through proprietary software that analyzes various qualitative and quantitative factors. Growth rate and CAGR were estimated through intensive secondary and primary research. Data triangulation across various data points provides accuracy across various analyzed market segments in the report. Application of both top down and bottom-up approach for validation of market estimation assures logical, methodical and mathematical consistency of the quantitative data.

Market Segmentation

Phase

    • Phase I
    • Phase II
    • Phase III
    • Phase IV

Participant

    • Pediatrics
    • Adults
    • Geriatrics

Study Design

    • Interventional Trials
    • Observational Trials
    • Expanded Access Trials

Type

    • Systemic Edema
    • Localized Edema

Region Segment (2021-2031; US$ Million)

North America

U.S.

Canada

Rest of North America

UK and European Union

UK

Germany

Spain

Italy

France

Rest of Europe

Asia Pacific

China

Japan

India

Australia

South Korea

Rest of Asia Pacific

Latin America

Brazil

Mexico

Rest of Latin America

Middle East and Africa

GCC

Africa

Rest of Middle East and Africa

Key questions answered in this report

What are the key micro and macro environmental factors that are impacting the growth of Edema Clinical Trials market?

What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?

Estimated forecast and market projections up to 2031.

Which segment accounts for the fastest CAGR during the forecast period?

Which market segment holds a larger market share and why?

Are low and middle-income economies investing in the Edema Clinical Trials market?

Which is the largest regional market for Edema Clinical Trials market?

What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?

Which are the key trends driving Edema Clinical Trials market growth?

Who are the key competitors and what are their key strategies to enhance their market presence in the Edema Clinical Trials market worldwide?

Table of Contents

1. Preface

  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. Target Audience
    • 1.1.3. Key Offerings
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
    • 1.3.1. Phase I - Secondary Research
    • 1.3.2. Phase II - Primary Research
    • 1.3.3. Phase III - Expert Panel Review
    • 1.3.4. Assumptions
    • 1.3.5. Approach Adopted

2. Executive Summary

  • 2.1. Market Snapshot: Global Edema Clinical Trials Market
  • 2.2. Global Edema Clinical Trials Market, By Phase, 2022 (US$ Million)
  • 2.3. Global Edema Clinical Trials Market, By Participant, 2022 (US$ Million)
  • 2.4. Global Edema Clinical Trials Market, By Study Design, 2022 (US$ Million)
  • 2.5. Global Edema Clinical Trials Market, By Type, 2022 (US$ Million)
  • 2.6. Global Edema Clinical Trials Market, By Geography, 2022 (US$ Million)
  • 2.7. Attractive Investment Proposition by Geography, 2022

3. Edema Clinical Trials Market: Competitive Analysis

  • 3.1. Market Positioning of Key Edema Clinical Trials Market Vendors
  • 3.2. Strategies Adopted by Edema Clinical Trials Market Vendors
  • 3.3. Key Industry Strategies
  • 3.4. Tier Analysis 2022 Versus 2031

4. Edema Clinical Trials Market: Macro Analysis & Market Dynamics

  • 4.1. Introduction
  • 4.2. Global Edema Clinical Trials Market Value, 2021 - 2031, (US$ Million)
  • 4.3. Market Dynamics
    • 4.3.1. Market Drivers
    • 4.3.2. Market Restraints
    • 4.3.3. Key Challenges
    • 4.3.4. Key Opportunities
  • 4.4. Impact Analysis of Drivers and Restraints
  • 4.5. See-Saw Analysis
  • 4.6. Porter's Five Force Model
    • 4.6.1. Supplier Power
    • 4.6.2. Buyer Power
    • 4.6.3. Threat Of Substitutes
    • 4.6.4. Threat Of New Entrants
    • 4.6.5. Competitive Rivalry
  • 4.7. PESTEL Analysis
    • 4.7.1. Political Landscape
    • 4.7.2. Economic Landscape
    • 4.7.3. Technology Landscape
    • 4.7.4. Legal Landscape
    • 4.7.5. Social Landscape

5. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)

  • 5.1. Market Overview
  • 5.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 5.3. Market Segmentation
    • 5.3.1. Phase I
    • 5.3.2. Phase II
    • 5.3.3. Phase III
    • 5.3.4. Phase IV

6. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)

  • 6.1. Market Overview
  • 6.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 6.3. Market Segmentation
    • 6.3.1. Pediatrics
    • 6.3.2. Adults
    • 6.3.3. Geriatrics

7. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)

  • 7.1. Market Overview
  • 7.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 7.3. Market Segmentation
    • 7.3.1. Interventional Trials
    • 7.3.2. Observational Trials
    • 7.3.3. Expanded Access Trials

8. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

  • 8.1. Market Overview
  • 8.2. Growth & Revenue Analysis: 2022 Versus 2031
  • 8.3. Market Segmentation
    • 8.3.1. Systemic Edema
    • 8.3.2. Localized Edema

9. North America Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 9.1. Market Overview
  • 9.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 9.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 9.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 9.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 9.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 9.6.1.North America
      • 9.6.1.1. U.S.
        • 9.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 9.6.1.2. Canada
        • 9.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 9.6.1.3. Rest of North America
        • 9.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 9.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 9.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 9.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

10. UK and European Union Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 10.1. Market Overview
  • 10.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 10.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 10.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 10.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 10.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 10.6.1.UK and European Union
      • 10.6.1.1. UK
        • 10.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.2. Germany
        • 10.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.3. Spain
        • 10.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.4. Italy
        • 10.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.5. France
        • 10.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 10.6.1.6. Rest of Europe
        • 10.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 10.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 10.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 10.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

11. Asia Pacific Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 11.1. Market Overview
  • 11.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 11.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 11.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 11.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 11.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 11.6.1.Asia Pacific
      • 11.6.1.1. China
        • 11.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.2. Japan
        • 11.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.3. India
        • 11.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.4. Australia
        • 11.6.1.4.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.4.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.4.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.4.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.5. South Korea
        • 11.6.1.5.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.5.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.5.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.5.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 11.6.1.6. Rest of Asia Pacific
        • 11.6.1.6.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 11.6.1.6.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 11.6.1.6.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 11.6.1.6.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

12. Latin America Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 12.1. Market Overview
  • 12.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 12.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 12.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 12.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 12.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 12.6.1.Latin America
      • 12.6.1.1. Brazil
        • 12.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 12.6.1.2. Mexico
        • 12.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 12.6.1.3. Rest of Latin America
        • 12.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 12.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 12.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 12.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

13. Middle East and Africa Edema Clinical Trials Market, 2021-2031, USD (Million)

  • 13.1. Market Overview
  • 13.2. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
  • 13.3. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
  • 13.4. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
  • 13.5. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
  • 13.6.Edema Clinical Trials Market: By Region, 2021-2031, USD (Million)
    • 13.6.1.Middle East and Africa
      • 13.6.1.1. GCC
        • 13.6.1.1.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.1.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.1.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.1.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 13.6.1.2. Africa
        • 13.6.1.2.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.2.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.2.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.2.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)
      • 13.6.1.3. Rest of Middle East and Africa
        • 13.6.1.3.1. Edema Clinical Trials Market: By Phase, 2021-2031, USD (Million)
        • 13.6.1.3.2. Edema Clinical Trials Market: By Participant, 2021-2031, USD (Million)
        • 13.6.1.3.3. Edema Clinical Trials Market: By Study Design, 2021-2031, USD (Million)
        • 13.6.1.3.4. Edema Clinical Trials Market: By Type, 2021-2031, USD (Million)

14. Company Profile

  • 14.1. Pfizer Inc.
    • 14.1.1. Company Overview
    • 14.1.2. Financial Performance
    • 14.1.3. Product Portfolio
    • 14.1.4. Strategic Initiatives
  • 14.2. Novartis AG
    • 14.2.1. Company Overview
    • 14.2.2. Financial Performance
    • 14.2.3. Product Portfolio
    • 14.2.4. Strategic Initiatives
  • 14.3. Johnson & Johnson
    • 14.3.1. Company Overview
    • 14.3.2. Financial Performance
    • 14.3.3. Product Portfolio
    • 14.3.4. Strategic Initiatives
  • 14.4. Otsuka Holdings
    • 14.4.1. Company Overview
    • 14.4.2. Financial Performance
    • 14.4.3. Product Portfolio
    • 14.4.4. Strategic Initiatives
  • 14.5. F. Hoffmann-La Roche Ltd.
    • 14.5.1. Company Overview
    • 14.5.2. Financial Performance
    • 14.5.3. Product Portfolio
    • 14.5.4. Strategic Initiatives
  • 14.6. Bayer
    • 14.6.1. Company Overview
    • 14.6.2. Financial Performance
    • 14.6.3. Product Portfolio
    • 14.6.4. Strategic Initiatives
  • 14.7. Genentech, Inc
    • 14.7.1. Company Overview
    • 14.7.2. Financial Performance
    • 14.7.3. Product Portfolio
    • 14.7.4. Strategic Initiatives
  • 14.8. Biogen
    • 14.8.1. Company Overview
    • 14.8.2. Financial Performance
    • 14.8.3. Product Portfolio
    • 14.8.4. Strategic Initiatives
  • 14.9. Inflammasome Therapeutics
    • 14.9.1. Company Overview
    • 14.9.2. Financial Performance
    • 14.9.3. Product Portfolio
    • 14.9.4. Strategic Initiatives
  • 14.10. Sanofi S.A.
    • 14.10.1. Company Overview
    • 14.10.2. Financial Performance
    • 14.10.3. Product Portfolio
    • 14.10.4. Strategic Initiatives
  • 14.11. OcuTerra Therapeutics
    • 14.11.1. Company Overview
    • 14.11.2. Financial Performance
    • 14.11.3. Product Portfolio
    • 14.11.4. Strategic Initiatives
  • 14.12. Other Notable Players
    • 14.12.1. Company Overview
    • 14.12.2. Financial Performance
    • 14.12.3. Product Portfolio
    • 14.12.4. Strategic Initiatives

List of Tables

  • TABLE 1 Global Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 2 Global Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 3 Global Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 4 Global Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 5 North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 6 North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 7 North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 8 North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 9 U.S. Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 10 U.S. Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 11 U.S. Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 12 U.S. Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 13 Canada Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 14 Canada Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 15 Canada Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 16 Canada Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 17 Rest of North America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 18 Rest of North America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 19 Rest of North America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 20 Rest of North America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 21 UK and European Union Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 22 UK and European Union Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 23 UK and European Union Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 24 UK and European Union Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 25 UK Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 26 UK Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 27 UK Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 28 UK Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 29 Germany Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 30 Germany Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 31 Germany Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 32 Germany Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 33 Spain Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 34 Spain Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 35 Spain Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 36 Spain Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 37 Italy Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 38 Italy Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 39 Italy Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 40 Italy Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 41 France Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 42 France Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 43 France Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 44 France Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 45 Rest of Europe Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 46 Rest of Europe Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 47 Rest of Europe Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 48 Rest of Europe Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 49 Asia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 50 Asia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 51 Asia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 52 Asia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 53 China Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 54 China Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 55 China Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 56 China Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 57 Japan Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 58 Japan Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 59 Japan Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 60 Japan Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 61 India Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 62 India Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 63 India Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 64 India Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 65 Australia Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 66 Australia Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 67 Australia Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 68 Australia Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 69 South Korea Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 70 South Korea Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 71 South Korea Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 72 South Korea Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 73 Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 74 Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 75 Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 76 Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 77 Brazil Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 78 Brazil Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 79 Brazil Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 80 Brazil Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 81 Mexico Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 82 Mexico Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 83 Mexico Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 84 Mexico Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 85 Rest of Latin America Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 86 Rest of Latin America Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 87 Rest of Latin America Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 88 Rest of Latin America Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 89 Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 90 Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 91 Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 92 Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 93 GCC Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 94 GCC Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 95 GCC Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 96 GCC Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 97 Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 98 Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 99 Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 100 Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)
  • TABLE 101 Rest of Middle East and Africa Edema Clinical Trials Market By Phase, 2021-2031, USD (Million)
  • TABLE 102 Rest of Middle East and Africa Edema Clinical Trials Market By Participant, 2021-2031, USD (Million)
  • TABLE 103 Rest of Middle East and Africa Edema Clinical Trials Market By Study Design, 2021-2031, USD (Million)
  • TABLE 104 Rest of Middle East and Africa Edema Clinical Trials Market By Type, 2021-2031, USD (Million)

List of Figures

  • FIG. 1 Global Edema Clinical Trials Market: Market Coverage
  • FIG. 2 Research Methodology and Data Sources
  • FIG. 3 Market Size Estimation - Top Down & Bottom-Up Approach
  • FIG. 4 Global Edema Clinical Trials Market: Quality Assurance
  • FIG. 5 Global Edema Clinical Trials Market, By Phase, 2022
  • FIG. 6 Global Edema Clinical Trials Market, By Participant, 2022
  • FIG. 7 Global Edema Clinical Trials Market, By Study Design, 2022
  • FIG. 8 Global Edema Clinical Trials Market, By Type, 2022
  • FIG. 9 Global Edema Clinical Trials Market, By Geography, 2022
  • FIG. 10 Market Geographical Opportunity Matrix - Global Edema Clinical Trials Market, 2022

FIG. 11Market Positioning of Key Edema Clinical Trials Market Players, 2022

FIG. 12Global Edema Clinical Trials Market - Tier Analysis - Percentage of Revenues by Tier Level, 2022 Versus 2031

  • FIG. 13 Global Edema Clinical Trials Market, By Phase, 2022 Vs 2031, %
  • FIG. 14 Global Edema Clinical Trials Market, By Participant, 2022 Vs 2031, %
  • FIG. 15 Global Edema Clinical Trials Market, By Study Design, 2022 Vs 2031, %
  • FIG. 16 Global Edema Clinical Trials Market, By Type, 2022 Vs 2031, %
  • FIG. 17 U.S. Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 18 Canada Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 19 Rest of North America Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 20 UK Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 21 Germany Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 22 Spain Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 23 Italy Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 24 France Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 25 Rest of Europe Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 26 China Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 27 Japan Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 28 India Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 29 Australia Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 30 South Korea Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 31 Rest of Asia Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 32 Brazil Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 33 Mexico Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 34 Rest of Latin America Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 35 GCC Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 36 Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031
  • FIG. 37 Rest of Middle East and Africa Edema Clinical Trials Market (US$ Million), 2021 - 2031